These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8326418)

  • 1. Symposium on antimicrobial therapy. IX. The glycopeptide and macrolide antibiotics.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jun; 86(6):269-75. PubMed ID: 8326418
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between copper, glycopeptide, and macrolide resistance among Enterococcus faecium strains isolated from pigs in Denmark between 1997 and 2003.
    Hasman H; Aarestrup FM
    Antimicrob Agents Chemother; 2005 Jan; 49(1):454-6. PubMed ID: 15616335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for the indication-justified use of antibiotics. 3: macrolides, lincosamide, glycopeptide antibiotics, fusidic acid, fosfomycin].
    Halle E; Briedigkeit H
    Z Arztl Fortbild (Jena); 1991 Dec; 85(24):1197-9. PubMed ID: 1776300
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.
    Biavasco F; Montanari MP; Facinelli B; Varaldo PE
    J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current antimicrobial drugs].
    van Kasteren ME; Natsch S; van der Meer JW
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2392-6. PubMed ID: 9554159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs.
    Boerlin P; Wissing A; Aarestrup FM; Frey J; Nicolet J
    J Clin Microbiol; 2001 Nov; 39(11):4193-5. PubMed ID: 11682559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity (invitro) of certain polyene macrolide antibiotics against various plant pathogens.
    Bhat JM; Narayanan MS
    Hindustan Antibiot Bull; 1996; 38(1-4):32-6. PubMed ID: 9676042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of antibiotics in the treatment of bronchial asthma].
    Dziedziczko A
    Pol Merkur Lekarski; 2003 Jun; 14(84):653-7. PubMed ID: 14524294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus.
    Gould IM
    Int J Antimicrob Agents; 2008 Apr; 31 Suppl 2():1-9. PubMed ID: 18485997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolides: present and future. An appraisal of in-vitro activity and pharmacokinetic behavior.
    Furneri PM; Nicoletti G
    J Chemother; 1991 Jan; 3 Suppl 1():24-7. PubMed ID: 12041776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of novel bifunctional macrolides.
    Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance mediated by a Bifidobacterium breve membrane protein.
    Margolles A; Moreno JA; van Sinderen D; de Los Reyes-Gavilán CG
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4379-81. PubMed ID: 16189127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial drug therapy and microbial sensitivity tests--antibiotics and microbial sensitivity tests].
    Kanno H
    Rinsho Byori; 1997 Jul; Suppl 105():174-81. PubMed ID: 9379537
    [No Abstract]   [Full Text] [Related]  

  • 19. Strain-specific expression levels of pbp4 exist in isolates of glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA.
    Wootton M; Bennett PM; MacGowan AP; Walsh TR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3598-9. PubMed ID: 16048995
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in the activity of macrolide and beta-lactam antibiotics and resistance development. Alexander Project Group.
    Schito GC; Mannelli S; Pesce A
    J Chemother; 1997 May; 9 Suppl 3():18-28. PubMed ID: 9248977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.